Vivo Opportunity, LLC

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 12. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 12
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
InMed Pharmaceuticals Inc.—Open-market buy$32 sharesJul 16, 2026InMed Pharmaceuticals Inc.$3Buy · Jul 16Open-market buy2Jul 16, 2026
InMed Pharmaceuticals Inc.—Open-market buy$2919 sharesJul 16, 2026InMed Pharmaceuticals Inc.$29Buy · Jul 16Open-market buy19Jul 16, 2026
InMed Pharmaceuticals Inc.—Open-market buy$2,1531,389 sharesJul 16, 2026InMed Pharmaceuticals Inc.$2,153Buy · Jul 16Open-market buy1,389Jul 16, 2026
InMed Pharmaceuticals Inc.—Open-market buy$21,33013,761 sharesJul 16, 2026InMed Pharmaceuticals Inc.$21,330Buy · Jul 16Open-market buy13,761Jul 16, 2026
InMed Pharmaceuticals Inc.—Open-market buy$764493 sharesJul 16, 2026InMed Pharmaceuticals Inc.$764Buy · Jul 16Open-market buy493Jul 16, 2026